| No headlines available for JGLIX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 2.33M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 22.10% | | 5y Avg Return: | 6.33% | | Rank in Category (ytd): | 56 | | % Rank in Category (ytd): | 33.94% | | Beta (3y): | 0.74 | | Morningstar Risk Rating: | Average |
|
| The investment seeks long-term growth of capital. The fund invests normally at least 80% of assets in securities of companies that the portfolio managers believe have a life science orientation. It invests primarily in equity securities of U.S. and foreign companies selected for their growth potential. The fund normally invests at least 25% of assets in the life sciences sector, which may include companies in the following industries: health care; pharmaceuticals; agriculture; cosmetics/personal care; and biotechnology. It may have significant exposure to emerging markets. | | | Fund Profile |
|
Help
0.08 (0.80%) 
Summary
Add JGLIX to Portfolio 
Download Data
